Yu-Wei Wang Selected Research

Yu-Wei Wang Research Topics

Disease

12	Neoplasms (Cancer) 10/2022 - 01/2014
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 10/2017
3	Stroke (Strokes) 06/2021 - 01/2020
3	Lung Neoplasms (Lung Cancer) 01/2021 - 07/2014
2	Sepsis (Septicemia) 06/2022 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 12/2014 - 01/2014
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 06/2008 - 01/2008
1	Frailty 06/2022
1	Aortic Valve Stenosis (Aortic Stenosis) 06/2022
1	Acute Kidney Injury (Acute Renal Failure) 06/2022
1	Intracranial Hypotension 05/2022
1	Osteoporotic Fractures 01/2022
1	Acute Lung Injury 05/2021
1	Lung Injury 05/2021
1	Edema (Dropsy) 05/2021
1	Disease Progression 01/2021
1	COVID-19 01/2021
1	Hepatitis B 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2020
1	Carcinogenesis 11/2020
1	Low Back Pain (Lumbago) 10/2020
1	Inflammation (Inflammations) 02/2020
1	Pathologic Processes 02/2020
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 02/2020
1	Death (Near-Death Experience) 01/2020
1	Heart Failure 01/2020
1	Myocardial Infarction 01/2020
1	Stable Angina 01/2020
1	Triple Negative Breast Neoplasms 09/2018
1	Arthritis (Polyarthritis) 03/2018
1	Hemorrhage 01/2017
1	Infections 01/2017
1	Purpura 01/2017
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2017
1	Dengue (Dengue Fever) 01/2017
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Cysts 11/2016
1	Neoplasm Metastasis (Metastasis) 11/2015

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 10/2021 - 11/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2014
2	Pharmaceutical PreparationsIBA 11/2020 - 01/2008
2	RNA (Ribonucleic Acid)IBA 02/2020 - 01/2019
2	MicroRNAs (MicroRNA)IBA 02/2020 - 07/2014
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 06/2022
1	loganinIBA 06/2022
1	TicagrelorIBA 06/2022
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 06/2022
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2022
1	Coe Comfort (FITT)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	hydroxide ionIBA 01/2022
1	Vitamin D-Binding ProteinIBA 01/2022
1	EnzymesIBA 10/2021
1	IonsIBA 10/2021
1	CationsIBA 10/2021
1	Ion Channels (Ion Channel)IBA 10/2021
1	2- (3,4- dimethoxybenzyl)- 7- (1- (1- hydroxyethyl)- 4- phenylbutyl)- 5- methylimidazo(5,1- f)(1,2,4)triazin- 4 (3H)-oneIBA 06/2021
1	cadherin 5IBA 05/2021
1	ruscogeninIBA 05/2021
1	Particulate MatterIBA 05/2021
1	nanolucIBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	blasticidin S deaminaseIBA 01/2021
1	TransferasesIBA 01/2021
1	Neomycin FDA LinkGeneric 01/2021
1	PuromycinIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	LuciferasesIBA 01/2021
1	BilirubinIBA 01/2021
1	dolutegravirIBA 11/2020
1	CalciumIBA 11/2020
1	atractylodinIBA 09/2020
1	Biological ProductsIBA 02/2020
1	chelidonineIBA 01/2020
1	Gefitinib (Iressa)FDA Link 01/2020
1	IvabradineIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020
1	Pyruvate KinaseIBA 11/2018
1	Protein Isoforms (Isoforms)IBA 11/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2018
1	Capecitabine (Xeloda)FDA Link 09/2018
1	apatinibIBA 09/2018
1	mangostinIBA 03/2018
1	Phosphotransferases (Kinase)IBA 10/2017
1	Immunoglobulin G (IgG)IBA 01/2017
1	Immunoglobulin A (IgA)IBA 01/2017
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2017
1	Parathyroid Hormone-Related ProteinIBA 11/2015

Therapy/Procedure

9	Therapeutics 10/2022 - 01/2009
1	Transcatheter Aortic Valve Replacement 06/2022
1	Aftercare (After-Treatment) 06/2022
1	Epidural Blood Patch 05/2022
1	Intraperitoneal Injections 09/2020
1	Resuscitation Orders (Do Not Resuscitate Orders) 01/2020
1	Immunotherapy 01/2020
1	Length of Stay 01/2020